TRex Bio, Inc. · NASDAQ:TRXB
ELI LILLY & Co reported a 19.90% stake in TRex Bio, Inc. (Schedule 13D)
Event Oct 13, 2026 · Filed Oct 16, 2026
ELI LILLY & Co reported a 19.90% stake in TRex Bio, Inc., 5,480,872 shares, with active intent on Oct 13, 2026. Filed Oct 16, 2026 (Schedule 13D).
- Stake
- 19.90%
- Shares
- 5,480,872
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ELI LILLY & Co | 19.90% | 5,480,872 |
Source
Download original · View original at SEC
Related
- TRex Bio, Inc.
- ELI LILLY & Co
- TRex Bio, Inc. shareholders
- Schedule 13D · SV Biotech Crossover Opportunities Fund LP · Oct 16, 2026
- Schedule 13G · Pfizer Inc · Oct 16, 2026
- Form 4 · Alexandria Venture Investments, LLC · Oct 15, 2026
- Schedule 13G · Johnson & Johnson Innovation - JJDC, Inc. · Oct 15, 2026
- Form 4 · Marcus Joel S · Oct 13, 2026